In March 2014, the PBS approved the use of injection therapy for prophylaxis of headaches in adult patients in Australia who are suffering from chronic migraines. They must fulfil the following criteria:
- Patient has experienced an average of 15 or more headache days per month, with at least 8 days of migraine, over a period of at least 6 months
- Inadequate response, intolerance or contraindication to at least three migraine medications:
- Propanolol (Deralin, Inderal)
- Amitryptylline (Endep)
- Methylsergide (Deseril)
- Pizotifen (Sandomigran)
- Cyproheptadine (Periactin)
- Topiramate (Topamax)
In addition, patients who have migraine medication overuse headaches must be appropriately managed.
The PBS based its approval on the results from a large multicenter study in Australia, the PREEMPT, that compared the injection therapy to injections of placebo administered via a randomised, double-blind design. This study demonstrated the injection therapy to be both safe and effective for the treatment of this chronic pain, when conducted by a headache specialist.
The injection therapy is a natural, purified protein. It is a prescription only medicine and should only be administered for chronic migraines by a neurologist or specialist who has undergone extra training specifically for the use of this therapy. Our migraine treatment centre in Brisbane has an experienced migraine specialist available to conduct this procedure.
In addition, neurologists and headache specialists are the only medical practitioners in Brisbane, and throughout Australia, who meet the eligibility requirements for a Medicare rebate for the migraine treatment procedure.
To find out more about our headache specialist in Brisbane, migraine medication and treatments, please contact our team on (07) 3831 1611.